Exploring the Effects of Exercise Combined With BFRT on Healthy and Patients With CKD
The Feasibility and Effects of Exercise Training Combined With Blood Flow Restriction Training on Exercise Capacity and Exercise Tolerance in Patients With Chronic Kidney Disease
1 other identifier
interventional
120
1 country
1
Brief Summary
Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in healthy and CKD patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2025
CompletedFirst Submitted
Initial submission to the registry
November 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
December 17, 2025
December 1, 2025
2.2 years
November 16, 2025
December 3, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Diaphragm excursion and thickness
Diaphragm excursion (unit: mm) and thickness (unit: mm) are examined by diaphragmatic ultrasound when a participant performs maximal inspiration and expiration
Change from baseline (0 week) to follow up (16 weeks)
Exercise capacity
A cardiopulmonary exercise test collects gases (including measures of oxygen consumption in ml/kg/min), which can be used to estimate exercise capacity
Change form baseline (0 week) to follow up (16 weeks)
Secondary Outcomes (18)
Heart rate variability (Standard Deviation of Normal-to-Normal Intervals, SDNN)
Change form baseline (0 week) to follow up (16 weeks)
Heart rate variability (Root Mean Square of Successive Differences, RMSSD)
Change form baseline (0 week) to follow up (16 weeks)
Heart rate variability (Low Frequency power, LF)
Change form baseline (0 week) to follow up (16 weeks)
Heart rate variability (High Frequency power, HF)
Change from baseline (0 week) to follow-up (16 weeks)
Heart rate variability (LF/HF Ratio)
Change from baseline (0 week) to follow-up (16 weeks)
- +13 more secondary outcomes
Study Arms (4)
healthy
EXPERIMENTALWe will provide BFR combined with exercise
CKD usual care group
ACTIVE COMPARATORWe will provide patient education, home-based moderate to low-intensity rehabilitation
CKD traditional rehabilitation group
ACTIVE COMPARATORWe will provide aerobic exercise, resistance exercise training, and patient education
CKD BFR group
EXPERIMENTALWe will provide BFR combined with exercise and patient education
Interventions
The aerobic exercise intervention will utilize stationary bike. The program will be conducted 2 times per week over a 12 weeks
Blood flow restriction intervention will combined aerobic exercise and resistance exercise. The program will be conducted 2 times per week over a 12 weeks
The resistance exercise will bilateral leg extension. The program will be conducted 2 times per week over a 12 weeks
The participants will received self-care technique and home-based exercise approach
Eligibility Criteria
You may qualify if:
- Aged 20\~85 years old
You may not qualify if:
- Severe uncontrolled metabolic diseases (e.g., hyperthyroidism, diabetes, hypertension, hyperlipidemia, etc.)
- Severe pulmonary or cardiovascular diseases (e.g., pulmonary hypertension, chronic obstructive pulmonary disease (COPD), heart failure, cardiac arrhythmia)
- Presence of a cardiac pacemaker or a history of myocardial infarction within the past six months
- Severe musculoskeletal or neuromuscular disorders (e.g., advanced arthritis, limb amputation, post-polio syndrome, Parkinson's disease)
- Unstable vital signs (e.g., systolic blood pressure ≥180 mmHg, diastolic blood pressure ≥90 mmHg, requiring vasopressors, or resting heart rate \>100 bpm)
- Prone to bruising
- Recent inflection \< 1 month
- Pregnancy
- Kidney function impairment
- Cancer
- Simultaneously participating in other research
- CKD
- Aged 20\~85 years old
- eGFR\< 90 ml/min/1.73 m2 over 3 months
- Stable condition without worsening in the past 3 months
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Cheng Kung University Hospital
Tainan, 701, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kun-Ling Tasi, PhD
Department of Physical Therapy, National Cheng Kung University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chair, Department of Physical Therapy
Study Record Dates
First Submitted
November 16, 2025
First Posted
December 17, 2025
Study Start
October 4, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2030
Last Updated
December 17, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
IPD sharing plan will be decided after summarized data being published